3PathaK A, Lebrin M, Vaccaro A, et al. Pharmacology of levosimen- dan: inotropie, vasodilatory and eardioproteetive effects [ J ]. J Clin Pharm Ther,2013,38 ( 5 ) :341-349.
4Nieminen MS, Fruhwald S, Heunks LM, et al. Levosimendan : current data,clinical use and future development [ J ]. Heart Lung Vessel, 2013,5(4) :227-245.
5Papp Z, Csapo K, Pollesello P, et al. Pharmacological contributing to the clinical efficacy of levosimendan [ J ] Drug Rev ,2005,23 ( 1 ) :71-98.
6Cardiovasc Hodt A,Steine K,Atar D. Medical and ventilatory treatment of acute heart failure : new insights[ J]. Cardiology ,2006,106 ( 1 ) : 1-9.
7Duygu H, Ozerkan F, Zoghi M, et al. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure[ J]. Int J Clin Pract,2008,62(2) :228-233.
8Yilmaz MB,Yontar C, Erdem A,et al. Comparative effects of levosi- mendan and dobutamine on right ventricular function in patients with biventricular heart failure [ J ]. Heart Vessels,2009,24 ( 1 ) : 16-21.
10Ikonomidis I, Parissis JT, Paraskevaidis I, et al. Effects of levosimen- dan on coronary artery flow and cardiac performance in patients with advanced heart failure[J]. Eur J Heart Fail, 2007,9 ( 12 ) : 1172 - 1177.
